Annual Total Expenses
$38.08 M
+$9.16 M+31.67%
31 December 2023
Summary:
SAB Biotherapeutics annual total expenses is currently $38.08 million, with the most recent change of +$9.16 million (+31.67%) on 31 December 2023. During the last 3 years, it has risen by +$58.63 million (+285.22%). SABS annual total expenses is now at all-time high.SABS Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$11.31 M
+$1.11 M+10.86%
30 September 2024
Summary:
SAB Biotherapeutics quarterly total expenses is currently $11.31 million, with the most recent change of +$1.11 million (+10.86%) on 30 September 2024. Over the past year, it has increased by +$5.99 million (+112.47%). SABS quarterly total expenses is now -40.08% below its all-time high of $18.87 million, reached on 31 December 2023.SABS Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SABS Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +31.7% | +112.5% |
| 3 y3 years | +285.2% | +183.4% |
| 5 y5 years | - | - |
SABS Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +285.2% | -40.1% | +183.4% |
| 5 y | 5 years | at high | +285.2% | -40.1% | +1489.5% |
| alltime | all time | at high | +285.2% | -40.1% | +1489.5% |
SAB Biotherapeutics Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $11.31 M(+10.9%) |
| June 2024 | - | $10.20 M(-10.4%) |
| Mar 2024 | - | $11.39 M(-39.6%) |
| Dec 2023 | $38.08 M(+31.7%) | $18.87 M(+254.6%) |
| Sept 2023 | - | $5.32 M(-17.8%) |
| June 2023 | - | $6.48 M(-12.5%) |
| Mar 2023 | - | $7.40 M(-5.8%) |
| Dec 2022 | $28.92 M | $7.86 M(+0.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $7.81 M(+19.3%) |
| June 2022 | - | $6.54 M(-2.5%) |
| Mar 2022 | - | $6.71 M(-8.7%) |
| Dec 2021 | $13.39 M(-165.2%) | $7.34 M(+84.0%) |
| Sept 2021 | - | $3.99 M(+38.9%) |
| June 2021 | - | $2.87 M(-452.9%) |
| Mar 2021 | - | -$813.90 K |
| Dec 2020 | -$20.56 M(-269.7%) | - |
| Dec 2019 | $12.12 M | - |
FAQ
- What is SAB Biotherapeutics annual total expenses?
- What is the all time high annual total expenses for SAB Biotherapeutics?
- What is SAB Biotherapeutics annual total expenses year-on-year change?
- What is SAB Biotherapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for SAB Biotherapeutics?
- What is SAB Biotherapeutics quarterly total expenses year-on-year change?
What is SAB Biotherapeutics annual total expenses?
The current annual total expenses of SABS is $38.08 M
What is the all time high annual total expenses for SAB Biotherapeutics?
SAB Biotherapeutics all-time high annual total expenses is $38.08 M
What is SAB Biotherapeutics annual total expenses year-on-year change?
Over the past year, SABS annual total expenses has changed by +$9.16 M (+31.67%)
What is SAB Biotherapeutics quarterly total expenses?
The current quarterly total expenses of SABS is $11.31 M
What is the all time high quarterly total expenses for SAB Biotherapeutics?
SAB Biotherapeutics all-time high quarterly total expenses is $18.87 M
What is SAB Biotherapeutics quarterly total expenses year-on-year change?
Over the past year, SABS quarterly total expenses has changed by +$5.99 M (+112.47%)